RSA Viewpoints
Inspiring Leaders | Prof. Helga Rübsamen-Schaeff
A chemist by training, Professor Helga Rübsamen-Schaeff started her career as Scientific and Executive Director of an academic institution, the Chemotherapeutical Research Institute Georg-Speyer-Haus...
Inspiring Leaders | Dr Antonin de Fougerolles
With over 20 years of biotech R&D experience building out drug pipelines and helping drive several multi-billion-dollar companies from start-up, Tony is one of...
What will we need from Life Sciences leaders in 2021?
As a follow up to my recent blogs, I would like to share some further reflections about what Executive Leaders and Board members in...
Inspiring Leaders | Dr Melanie Lee, PhD, CBE
Begin Each Decade Anew – This is the incredible story of LifeArc’s CEO, Dr Melanie Lee, PhD, CBE. Prior to joining LifeArc Melanie pursued...
Inspiring Leaders | Michelle Tempest
Our next featured Inspiring Leader is the amazing Michelle Tempest, Partner at Candesic and author of ‘Big Brain Revolution: Artificial Intelligence Spy or Saviour?‘...
Inspiring Leaders | Angela Hildreth
Our next story in the Inspiring Leaders series comes from the phenomenal Angela Hildreth, Finance Director and Chief Operating Officer at Futura Medical. We...
Inspiring Leaders | Baroness Susan Greenfield
As a continuation of our Inspiring Leaders Series we were lucky enough to interview the amazing Baroness Susan Greenfield who is CEO and Founder...
Inspiring Leaders | Shiva Dustdar
We were honoured to speak to Shiva Dustdar who is Head of Division, Innovation Finance Advisory for the European Investment Bank. In this blog...
Inspiring Leaders | Jo Pisani Part Two
The professional world has evolved at exponential pace since I started my first role at BP and more women are pushing forward and moving...
Inspiring Leaders | Jo Pisani Part One
Early influences on my journey into science and leadership I always liked the sciences at school, and I also loved to take things apart...
My experience as a research intern during the pandemic
Like so many of my fellow undergraduates earlier this year, I felt disheartened and discouraged by the volume of rejected internship applications filling my...
From academia to industry: insights on how to make the move
Making the transition from academia to industry can be a challenging step, both for new graduates and seasoned researchers. In this blog, Daniel Cox,...
Further reflections from a Headhunter in Life Sciences who is (still) a realistic optimist
We all need a RQ (Reflective Intelligence Quotient) – we already have embraced IQ and EQ or ??? Having more time (no commute into...
Medical research charity Boards need to adapt to the new world or risk failure – Volume 2
In volume 1 of this blog, I looked at the tension caused by the growing demands on medical research charities and their heightened financial...
Medical research charity Boards need to adapt to the new world or risk failure – Volume 1
As we come out of the first wave of the Covid-19 pandemic, the issues affecting the Boards of medical research charities are, in many...
Reflections from a Headhunter in Life Sciences who is a realistic optimist – we need a new social contract!
In my self-isolating work from home arrangement since March, I am humbled that I have work to do and people to engage with. It’s...
What should pharma companies learn from the pandemic? Volume 2
Accelerated Evolution | The “New Normal” For the Pharma industry, Covid-19 has been a catalyst like no other. Even HIV in the 1980s wasn’t...
Never has the life sciences sector been more important – it’s time for Boards to raise their game
In recent conversations with investors, availability of the right people to join biotech Boards has come up as a recurring theme and the prevailing...